Among patients with Parkinson disease or parkinsonism undergoing a 30-day multidisciplinary intensive rehabilitation treatment (MIRT), consumption of a twice-daily whey protein-based nutritional supplement enriched with leucine and vitamin D preserved muscle mass and improved lower extremity function.
Galcanezumab, a monoclonal antibody against calcitonin gene-related peptide, may significantly improve daily functioning, disability, and health-related quality of life in a rapid and sustained fashion in patients with migraine.
Treatment with direct oral anticoagulants (DOAC) at discharge following acute ischemic stroke among patients with atrial fibrillation is an effective and safe treatment option, with a superior risk-benefit ratio compared with warfarin.
There have been 118 more reports of electronic cigarette users suffering seizures since the FDA first warned the public about the danger in April, bringing the total number of reported cases to 127 between 2010 and 2019.
Two similarly controlled landmark trials provide conflicting results regarding the clinical guidelines for management of acute hypertension in individuals with intracerebral hemorrhage. However, focusing exclusively on blood pressure targets may obscure a critical finding.
Stroke patients discharged with a case manager and access to an educational website reported significantly greater improvements in physical health after three months compared with those who had traditional care.
While AZD0530 is reasonably safe and well tolerated in participants with mild Alzheimer disease (AD), it has no significant effect on cerebral metabolic decline nor on clinical or biomarker measures in AD.
The incidence of neonatal abstinence syndrome has steadily and notably increased in Canada and researchers believe this increase highlights the importance of implementing integrated care for the mother-infant dyad during and after the birth process.